Weight loss cuts A-fib events in obese patients
“So this program was highly achievable and reproducible. We are not talking about drastic weight loss,” said McTiernan. The researchers measured levels of C-reactive protein, serum amyloid A, interleukin-6, leukocyte and neutrophil in 439 women. At the end of one year, C-reactive protein reduced by 36.1 percent in the diet-alone group and by 41.7 percent in the diet and exercise group.
For the original version including any supplementary images or video, visit http://medicalxpress.com/news/2012-05-weight-loss-reduction-inflammation.html
Over a 15-month period, the intervention group achieved greater reductions in weight compared with the routine care group — 14.3 kg vs. 3.6 kg (P<0.001), the researchers found. The single-center, partially blinded, randomized trial involved 150 overweight and obese ambulatory patientswith garcinia cambogia a BMI of 32.8 kg/m.2 All patients had symptomatic atrial fibrillation and half the patients were on at least one anti-arrhythmic medication. Patients were randomized in a 1:1 ratio to weight management (intervention) or general lifestyle advice (control) and were followed for a median of 15 months.
For the original version including any supplementary images or video, visit http://www.clinicaladvisor.com/weight-loss-cuts-a-fib-events-in-obese-patients/article/321473/